Clinical and diagnostic value of impairments in electrolyte metabolism in children with acquired myopia
Journal Title: Офтальмологический журнал - Year 2019, Vol 0, Issue 3
Abstract
Background: Identifying the biochemical features of the body in myopia associated with connective tissue dysplasia is still important in the ophthalmologist’s practice. Purpose: To assess the clinical and diagnostic value of impairments in electrolyte merabolism in children with acquired myopia. Methods: Group 1 included 30 children with mild myopia associated with the syndrome of unspecified connective tissue dysplasia (SUCTD), and Group 2 included 30 children with mild myopia without SUCTD. Group 3 (controls) included 30 pediatric healthy controls without ocular disease. Electrolyte balance was assessed by measuring magnesium, calcium, sodium, potassium and chloride ion concentrations in daily urine. Results: Magnesium and calcium ion concentrations in daily urine in children in Group 1 were significantly (2- and 1.7-fold, respectively) lower compared with children in Group 2, and significantly (2.1- and 1.9-fold, respectively) lower compared with controls (р < 0.05). There was no difference in sodium, potassium or chloride ion concentrations in daily urine among study groups. ROC analysis found that an optimum cutoff magnesium ion concentration of ≤2.3 mmol/day in daily urine was 97% sensitive and 80% specific, with an area under curve value (AUC) of 0.97±0.12 (CI 0.95-0.99) (р < 0.0001). In addition, an optimum cutoff calcium ion concentration of ≤3.42 mmol/day in daily urine was 96% sensitive and 85% specific, with an AUC value of 0.94±0.27 (CI 0.88-0.98) (р < 0.0001). Magnesium ion concentration in daily urine was moderately negatively correlated with dysplasia severity (r= -0.65, р < 0.05), and calcium ion concentration was moderately negatively correlated with dysplasia severity (r= -0.59, р < 0.05). Conclusion: The current study determined the diagnostic values of magnesium and calcium ion concentrations (≤ 2.3 mmol/day and ≤ 3.42 mmol/day, respectively) which can be used as biomarkers for laboratory screening for the presence of SUCTD in clinical practice.
Authors and Affiliations
T. Tsybulska, S. Gorbachova
Keywords
Related Articles
- EP ID EP597589
- DOI 10.31288/oftalmolzh201931419
- Views 79
- Downloads 0
Changes in the characteristics of superficial electromyography potentials recorded from the horizontal extraocular muscles in children with non-alternating nonaccommodative comitant strabismus after electrical stimulation treatment
Background: Electrical stimulation of lateral rectus muscles (LRM) is a physiotherapeutic technique used in the management of non-alternating nonaccommodative comitant strabismus (NNCS). Changes in the ocular neuromuscul...
Current antibacterial therapy for ocular burns
Background: Since ocular infection is common following ocular burns, and may lead to severe infectious complications like corneal ulcers, infiltrates and abscesses, prevention and treatment of these complications has bee...
Serum VEGF levels in infants at risk for developing retinopathy of prematurity
Background: Because excessive growth of abnormal retinal vessels in the developing eye of the premature infant underlies retinopathy of prematurity (ROP), it may be hypothesized that a change in vascular endothelial grow...
On the treatment of degeneration of the macula and posterior pole
Background: The field of degeneration of the macula and posterior pole (DMPP) is of outstanding medical and social significance as the disease is of high prevalence and leads to loss of general working capacity. Purpose...
Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma
Background: Secondary glaucoma is found in 18% to 38% of patients with uveitis, and is one of the most severe uveitic complications. The glaucomatous process is characterized by the progressive optic nerve neuropathy. Th...